Search results for "Drugs"

showing 10 items of 747 documents

Experience of Psychotropic Medication -An Interview Study of Persons with Psychosis.

2016

Psychotropic drugs, particularly antipsychotic types, are a cornerstone of the treatment of people with psychosis. Despite numerous studies showing that drug treatment with psychotropic drugs initially alleviates psychiatric symptoms, the proportion of people with mental health problems and symptoms that do not follow doctors' prescriptions, thus exhibiting so-called non-adherence, is considerable. Non-adherence is predominantly seen as a clinical feature and as a patient characteristic that is especially due to patients' poor understanding that they are ill. There is also a widespread notion that non-adherence is of great disadvantage to the patient. This article is based on interviews wit…

AdultMalePsychosismedicine.medical_specialtymedicine.medical_treatmentMedication adherencePsychotropic medicationMedication Adherence03 medical and health sciencesDrug treatmentYoung Adult0302 clinical medicinemedicineHumans030212 general & internal medicineYoung adultPatient participationAntipsychoticPsychiatryAgedPsychotropic Drugsbusiness.industryPatient PreferenceMiddle Agedmedicine.disease030227 psychiatryPsychotic DisordersInterview studyFemalePshychiatric Mental HealthPatient ParticipationbusinessClinical psychologyIssues in mental health nursing
researchProduct

Detection of gamma-hydroxybutyrate in hair: Validation of GC–MS and LC–MS/MS methods and application to a real case

2012

A gas chromatography-mass spectrometry (GC-MS) and a liquid chromatography tandem mass spectrometry (LC-MS/MS) method were validated for quantifying endogenous and exogenous hair concentrations of gamma-hydroxybutyrate (GHB). The GC-MS method is based on overnight extraction of 25 mg hair in NaOH at 56 °C, liquid/liquid extraction in ethylacetate and trimethylsylil derivatization; analysis is by electron ionization and single ion monitoring of three ions. The LC-MS/MS method entails a rapid digestion of 25 mg hair with NaOH at 75 °C for 40 min, liquid/liquid extraction in ethylacetate and reconstitution of the extract in the LC mobile phase; negative ion electrospray ionization and multiple…

AdultMaleQuality ControlSpectrometry Mass Electrospray IonizationSubstance-Related DisordersElectrospray ionizationClinical BiochemistryLiquid-Liquid ExtractionPharmaceutical ScienceAcetatesTandem mass spectrometryMass spectrometryGas Chromatography-Mass SpectrometryAnalytical ChemistryForensic ToxicologySettore MED/43 - Medicina LegaleLiquid chromatography–mass spectrometryLimit of DetectionTandem Mass SpectrometryDrug DiscoveryHumansSodium HydroxideSpectroscopyDetection limitChromatographyChemistryIllicit DrugsSelected reaction monitoringHair Segmental analysis GC–MS LC–MS/MSTemperatureReproducibility of ResultsGamma hydroxybutyrateReference StandardsSubstance Abuse DetectionGamma-hydroxybutyrate GHBCalibrationLinear ModelsCrimeGas chromatography–mass spectrometrySodium OxybateChromatography LiquidHair
researchProduct

Analysis of ecstasy in oral fluid by ion mobility spectrometry and infrared spectroscopy after liquid-liquid extraction.

2014

We developed and evaluated two different strategies for determining abuse drugs based on (i) the analysis of saliva by ion mobility spectrometry (IMS) after thermal desorption and (ii) the joint use of IMS and infrared (IR) spectroscopy after liquid-liquid microextraction (LLME) to enable the sensitivity-enhanced detection and double confirmation of ecstasy (MDMA) abuse. Both strategies proved effective for the intended purpose. Analysing saliva by IMS after thermal desorption, which provides a limit of detection (LOD) of 160μgL(-1), requires adding 0.2M acetic acid to the sample and using the truncated negative second derivative of the ion mobility spectrum. The joint use of IMS and IR spe…

AdultMaleSpectrophotometry InfraredIon-mobility spectrometryInfraredN-Methyl-34-methylenedioxyamphetamineLiquid-Liquid ExtractionThermal desorptionAnalytical chemistryInfrared spectroscopyBiochemistryAnalytical ChemistryIonLiquid–liquid extractionLimit of DetectionHumansSpectroscopySalivaDetection limitChromatographyChemistryIllicit DrugsOrganic ChemistryGeneral MedicineSubstance Abuse DetectionFemaleJournal of chromatography. A
researchProduct

S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharm…

2017

Structural and functional changes in the lateral temporal language areas have been related to formal thought disorder (FTD) in schizophrenia. Continuous, natural speech production activates the right lateral temporal lobe in schizophrenia, as opposed to the left in healthy subjects. Positive and negative FTD can be elicited in healthy subjects by glutamatergic NMDA blockade with ketamine. It is unclear whether the glutamate system is related to the reversed hemispheric lateralization during speaking in patients. In a double-blind, crossover, placebo-controlled study, 15 healthy, male, right-handed volunteers overtly described 7 pictures for 3 min each while BOLD signal changes were acquired…

AdultMaleSpeech productionmedicine.medical_specialtyAudiologyReceptors N-Methyl-D-AspartateBrain mappingPsychoses Substance-InducedLateralization of brain functionTemporal lobeThinking03 medical and health sciencesGlutamatergic0302 clinical medicineDouble-Blind Methodmental disordersmedicineHumansSpeechPsychiatryPharmacologyBrain MappingPsychotropic DrugsCross-Over StudiesThought disorderBrainmedicine.diseaseMagnetic Resonance Imaging030227 psychiatryOxygenPsychiatry and Mental healthSchizophreniaCerebrovascular CirculationVisual PerceptionNMDA receptorKetamineSchizophrenic PsychologyOriginal Articlemedicine.symptomPsychologyExcitatory Amino Acid Antagonists030217 neurology & neurosurgeryNeuropsychopharmacology
researchProduct

Use of alcohol, drugs, inhalants, and smoking tobacco and the long-term risk of depression in men: A nationwide Swedish cohort study from 1969–2017

2021

Background: The use of alcohol, drugs, inhalants, and smoking tobacco may lead to mood disorders such as depression. However, knowledge on the independent contributions of the use of these substances to the risk of depression is lacking. Methods: The study cohort consisted of 24,564 men included in the Swedish national military conscription register who were conscripted in 1969–1970 and followed until 2017. Cox proportional hazard ratios were used to estimate the risk of depression according to alcohol, drug, inhalant, and cigarette consumption, and adjusted for body mass index, verbal comprehension test scores, handgrip strength, and the other main exposures investigated. Results: During a…

AdultMaleSubstance-Related DisordersToxicologyCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsTobaccoTobacco SmokingMedicineHumansPharmacology (medical)030212 general & internal medicineAlcohol disorderDepression Drug abuse SmokingDepression (differential diagnoses)Proportional Hazards ModelsPharmacologySwedenPsychotropic DrugsHand Strengthbusiness.industryDepressionSmoking TobaccoHazard ratioSmokingTobacco ProductsMiddle Agedmedicine.diseaseSubstance abusePsychiatry and Mental healthMood disordersPharmaceutical PreparationsCohortFemalebusinessBody mass index030217 neurology & neurosurgeryDemographyCohort study
researchProduct

The synthetic cannabinoid 5F-MDMB-PICA: A case series

2020

5F-MDMB-PICA has been detected in products sold on the internet as well as in biological samples since 2016. It is associated with serious adverse health and behavioral effects and even death. Herein we report on twelve cases with proven 5F-MDMB-PICA consumption, including three fatalities, four cases of driving under the influence of drugs and five other criminal acts. In these cases, 5F-MDMB-PICA was detected in postmortem blood or serum. Concentrations ranged from 0.1-16ng/mL. In some blood (serum) and urine samples, the hydrolysis metabolite of 5F-MDMB-PICA (M12) could also be detected. In this case series, co-consumption with other drugs occurred in 9 of 12 cases, most commonly alcohol…

AdultMaleSubstance-Related Disordersmedicine.medical_treatmentPhysiology01 natural sciencesMass SpectrometryPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineLimit of DetectionPupil DisordersSynthetic cannabinoidsmedicineHumans030216 legal & forensic medicinePica (disorder)ConfusionAdverse effectDriving Under the InfluencePostural BalanceDriving under the influenceSlurred speechMolecular StructurebiologyCannabinoidsIllicit DrugsMood Disordersbusiness.industrySolid Phase Extraction010401 analytical chemistrycelebritiesPostmortem bloodMiddle Agedbiology.organism_classification0104 chemical sciencesAggressioncelebrities.reason_for_arrestSensation DisordersFemaleCrimeCannabinoidCannabismedicine.symptombusinessConjunctivaLawChromatography Liquidmedicine.drugForensic Science International
researchProduct

Efficacy and safety of topiramate in migraine prophylaxis: an open controlled randomized study comparing Sincronil and topamax formulations.

2013

AIM: Topiramate is a small molecule widely used for the treatment of epilepsy, migraine, bipolar disorders and alcoholism, and its availability as a generic formulation could significantly reduce the National Health Service expenditure. A generic formulation, available in Italy under the trademark Sincronil, recently showed superimposable blood levels, after oral administration to healthy volunteers, with the reference formulation. In the present study we report the results of an open label, parallel group, randomized, controlled study performed to evaluate the efficacy, tolerability and impact on disability of two different formulations of topiramate (Sincronil and Topamax) in patients wit…

AdultMaleTime Factorstopiramate migraineAdolescentChemistry PharmaceuticalMigraine DisordersFructoseMiddle AgedSeverity of Illness IndexYoung AdultTreatment OutcomeItalyTopiramateDrugs GenericHumansFemaleAgedCentral Nervous System Agents
researchProduct

A fatal paramethoxymethamphetamine intoxication.

2003

During the last years in Germany a marked increase in the use of amphetamines such as 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has been observed. The use of these recreational drugs is especially common among young people participating in rave parties. Occasionally ring-methoxylated phenethylamine derivatives like paramethoxymethamphetamine (PMMA) or paramethoxyamphetamine (PMA) are found in street drugs offered as ecstasy. These compounds exhibit a higher toxicity than the methylenedioxyamphetamine derivatives. We report on the death of a 22-year-old man after the ingestion of ecstasy pills containing PMMA and PMA. The PMMA concentration in femoral blood was 0.85 mg/l. Besides PMA…

AdultMalemedicine.drug_classEcstasyPharmacologyGas Chromatography-Mass SpectrometryPathology and Forensic MedicineMethamphetaminechemistry.chemical_compoundCocaineDopamine Uptake InhibitorsmedicineIngestionHumansAmphetamineChromatography High Pressure LiquidEthanolbusiness.industryIllicit DrugsAmphetaminesForensic toxicologyCentral Nervous System DepressantsMDMADesigner drugIssues ethics and legal aspectsAmphetaminechemistryPillBenzoylecgonineCentral Nervous System Stimulantsbusinessmedicine.drugLegal medicine (Tokyo, Japan)
researchProduct

Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemia.

2013

Summary Concerns have recently emerged about the quality of generic vancomycin products. Our aim is to analyze serum vancomycin concentrations measured 48 hours after the start of an empirical treatment regimen in patients with acute myeloid leukemia (AML) who received one of the two generic vancomycin products available in France. Patients and methods Seventy-nine AML patients treated with vancomycin during two study periods were included in the study. Our vancomycin dosing regimen was based on the patients’ total body weight adjusted for renal clearance. Results A total of 93 serum vancomycin concentrations were collected: 31 in period 1 and 62 in period 2. In bivariate analysis, the mean…

AdultMalemedicine.medical_specialtyAdolescentPharmaceutical ScienceKidneyGastroenterologyYoung AdultVancomycinInternal medicinemedicineDrugs GenericHumansIn patientGeneric ProductAgedRetrospective StudiesPharmacologybusiness.industryMyeloid leukemiaSerum concentrationMiddle AgedAnti-Bacterial AgentsRegimenLeukemia Myeloid AcuteImmunologyVancomycinFemaleHemoglobinbusinessmedicine.drugClearanceAnnales pharmaceutiques francaises
researchProduct

Mono-/polyintoxication with 5F-ADB: A case series.

2019

Abstract 5F-ADB is an indazole-based synthetic cannabinoid. In recent years, it has been detected in legal high products as well as in biological samples and is associated with serious adverse health, behavioral effects and even death. Due to the fast pace of the market of synthetic cannabinoids, data on such newly appearing substances are scarce. As pharmacological properties are often investigated in vitro or by using animal experiments, reports on synthetic cannabinoid findings in human samples along with corresponding case history descriptions are valuable for the interpretation of upcoming routine cases. Herein we report five cases with verified 5F-ADB consumption, including three fata…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentUnconsciousnessPathology and Forensic MedicineDesigner DrugsFatal OutcomeSynthetic cannabinoidsmedicineHumansAdverse effectIntensive care medicineConfusionDriving Under the InfluenceDriving under the influenceCollapse (medical)ConfusionMolecular Structurebusiness.industryCannabinoidscelebritiesMiddle Agedcelebrities.reason_for_arrestSubstance Abuse DetectionFemaleCannabinoidmedicine.symptombusinessLawSelf-Injurious Behaviormedicine.drugHairForensic science international
researchProduct